The letter came in June. Mindy McCormick, 67, read that her insurer would soon stop covering the weight loss drug Wegovy, which she had been taking for more than two years. What? she remembers thinking.

Up to a third of the weight lost while taking weight loss jabs such as Wegovy and Mounjaro includes muscle and bone mass.

Quartz spoke with Noom CEO Geoff Cook to get his take on what 2025 holds for the compounded drug market and the overall future of weight-loss drugs. Cook took over as CEO of the psychology-based weight loss app Noom in 2023,

Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with obesity-related conditions or take the drugs to become eligible for other services,

People struggling with their body weight experienced joy when new, more effective prescription drug options became the rage in 2023, but it seems many folks stopped taking them in 2024.

Prescriptions for weight-loss drugs surged in 2024 and were much more popular in some states, particularly those in the South with higher rates of obesity.

A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly “opens the possibility of an end to the obesity pandemic” alongside other interventions, the World Health Organization (WHO) said this week.

Are approved weight loss drugs unsafe? A UK woman and a Scottish nurse's death linked with popular weight loss drugs, raises questions on its safety? FDA has also issued warning.